Antiatherosclerotic therapy using cell differentiation-promoting effect of biologically active peptides
Antiatherosclerotic therapy using cell differentiation-promoting effect of biologically active peptides
批准号:
18590829
负责人:
HORIO Takeshi
金额:
$2.49万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We first examined the expression of receptors for natriuretic peptides(ANP, BNP, CNP) in wire-injured femoral arteries in mice. Significant expressions of both GC-A(receptor for ANP and BNP) and GC-B(receptor for CNP) were found in neointima after 3 weeks of wire injury, and the expression level of GC-A was higher than that of GC-B. When the extent of wire injury-induced neointima formation was compared between wild-type and GC-A knockout mice, the area of neointima was greater in GC-A knockout mice. This result suggested the possibility that endogenous ANP and BNP released from the heart inhibited atherosclerotic change of femoral artery after wire injury. To further examine the role of endogenous ANP and BNP in neovascularization observed in atherosclerotic lesions, lower limb-ischemic model was made in both wild-type and GC-A knockout mice, and the recovery of blood flow was evaluated. The blood flow was restored to about 70% after 3 weeks in wild-type mice. On the other hand, inter … More estingly, the recovery rate of blood flow in GC-A knockout mice was about 20%, and approximately half of them had necrotized lower limbs. The finding suggested that endogenous ANP and BNP might play an important role in the angiogenesis in ischemic lesions. From these results, an in vitro study was designed to investigate whether ANP and BNP, stimulate cyclic GMP(cGMP) accumulation in vascular endothelial progenitor cells derived from human blood mononuclear cells. As a result, intracellular cGMP levels were remarkably elevated after stimulation with ANP and BNP, suggesting that these peptides have a direct effect on endothelial progenitor cells. Our findings indicate that endogenous ANP and BNP are involved not only in the inhibition of the formation of atherosclerotic lesions, but also in the promotion of neovascularization in those lesions. Thus, the present study provided a great progress forclinical application of antiatherosclerotic therapy using cell differentiation-promoting effect of ANP and BNP. We will forward further investigations about antiatherosclerotic effects and therapeutic application of CNP, adrenomedulin, and ghrelin. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Plasma adrenomedullin as an independent predictor of future cardiovascular events in hypertensive patients.
血浆肾上腺髓质素作为高血压患者未来心血管事件的独立预测因子。
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Hidenori Nishida, et. al.]
通讯作者:
et. al.
高血圧性心不全-病態と診断・治療の現状 高血圧性心不全とナトリウム利尿ホルモン
高血压性心力衰竭——病理、诊断和治疗现状 高血压性心力衰竭与利尿钠激素
DOI:
--
发表时间:
2008
期刊:
血圧 15
影响因子:
--
作者:
[小山建一, 各務博, 堀尾武史]
通讯作者:
堀尾武史
Exogenous ghrelin attenuates the progression of chronic hypoxic-induced pulmonary hypertension in conscious rats.
外源性生长素释放肽可减轻清醒大鼠慢性缺氧诱导的肺动脉高压的进展。
DOI:
--
发表时间:
2008
期刊:
Endocrinology 149
影响因子:
--
作者:
[Daryl O. Schwenke, et. al.]
通讯作者:
et. al.
高血圧性心不全とナトリウム利尿ホルモン
高血压心力衰竭和利尿钠激素
DOI:
--
发表时间:
2008
期刊:
血圧 15
影响因子:
--
作者:
[Hidenori Nishida, et. al., 堀尾 武史]
通讯作者:
堀尾 武史
慢性心不全治療の進歩-成因と臨床研究-心不全の発症進展機序 サイトカイン
慢性心力衰竭的治疗进展 - 病因和临床研究 - 心力衰竭的发病和进展机制 细胞因子
DOI:
--
发表时间:
2006
期刊:
日本臨床 64
影响因子:
--
作者:
[Yoshio Iwashima, et. al., 堀尾武史]
通讯作者:
堀尾武史
共 42 条
Primary prevention of atrial fibrillation in hypertensive patients
-
批准号:25461079
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2013
-
负责人:HORIO Takeshi
-
依托单位:
DNA damage and immunosuppressive cytokines induced by ultraviolet radiation and chemical carcinogen
-
批准号:14570830
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2002
-
负责人:HORIO Takeshi
-
依托单位:
The Treatment of Atopic Dermatitis with PUVA Photochemotherapy : Clinical and Experimental Studies in Patients and Model Mice
-
批准号:11670854
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1999
-
负责人:HORIO Takeshi
-
依托单位:
The relationship between DNA damage and immunosuppression by ultraviolet radiation
-
批准号:09670901
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:HORIO Takeshi
-
依托单位:
海外基金